Resultados de búsqueda - Cecilia M. Fenoglio‐Preiser

  • Mostrando 1 - 10 Resultados de 10
Limitar resultados
  1. 1
    The future of prognostic factors in outcome prediction for patients with cancer

    The future of prognostic factors in outcome prediction for patients with cancer por L P Fielding, Cecilia M. Fenoglio‐Preiser, Laurence S. Freedman

    Publicado 1992
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  2. 2
    Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential

    Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential por S. Coverlizza, Mauro Risio, Andrea Ferrari, Cecilia M. Fenoglio‐Preiser, F. P. Rossini

    Publicado 1989
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  3. 3
    American Joint Committee on Cancer prognostic factors consensus conference

    American Joint Committee on Cancer prognostic factors consensus conference por Carolyn C. Compton, Cecilia M. Fenoglio‐Preiser, Norman M. Pettigrew, L P Fielding

    Publicado 2000
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  4. 4
    Serrated Polyps of the Large Intestine

    Serrated Polyps of the Large Intestine por Dale C. Snover, Jeremy R. Jass, Cecilia M. Fenoglio‐Preiser, Kenneth P. Batts

    Publicado 2005
    Enlace del recurso
    Carta
    Agregar a favoritos
    Guardado en:
  5. 5
    Cigarettes, alcohol, coffee, and caffeine as risk factors for colorectal adenomatous polyps

    Cigarettes, alcohol, coffee, and caffeine as risk factors for colorectal adenomatous polyps por Won Chul Lee, Alfred I. Neugut, Gail Garbowski, Kenneth A. Forde, Michael R. Treat, J. Ways, Cecilia M. Fenoglio‐Preiser

    Publicado 1993
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  6. 6
    Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer

    Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer por Syma Iqbal, Bryan Goldman, Cecilia M. Fenoglio‐Preiser, Heinz‐Josef Lenz, W. Zhang, K. D. Danenberg, Stephen Shibata, Charles D. Blanke

    Publicado 2011
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  7. 7
    The RON Receptor Tyrosine Kinase Mediates Oncogenic Phenotypes in Pancreatic Cancer Cells and Is Increasingly Expressed during Pancreatic Cancer Progression

    The RON Receptor Tyrosine Kinase Mediates Oncogenic Phenotypes in Pancreatic Cancer Cells and Is Increasingly Expressed during Pancreatic Cancer Progression por Ryan M. Thomas, Kenya Toney, Cecilia M. Fenoglio‐Preiser, Monica P. Revelo-Penafiel, Sunil R. Hingorani, David A. Tuveson, Susan E. Waltz, Andrew M. Lowy

    Publicado 2007
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  8. 8
    Phase II Trial of Erlotinib in Gastroesophageal Junction and Gastric Adenocarcinomas: SWOG 0127

    Phase II Trial of Erlotinib in Gastroesophageal Junction and Gastric Adenocarcinomas: SWOG 0127 por Tomislav Dragovich, Sheryl McCoy, Cecilia M. Fenoglio‐Preiser, Jiang Wang, Jacqueline Benedetti, Amanda F. Baker, Christopher B. Hackett, Susan G. Urba, Ken S. Zaner, Charles D. Blanke, James L. Abbruzzese

    Publicado 2006
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  9. 9
    Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation

    Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation por Craig J. Burd, Christin E. Petre, Lisa M. Morey, Ying Wang, Mónica P. Revelo, Christopher A. Haiman, Shan Lu, Cecilia M. Fenoglio‐Preiser, Jiwen Li, Erik S. Knudsen, Jiemin Wong, Karen E. Knudsen

    Publicado 2006
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  10. 10
    Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205

    Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S020... por Philip A. Philip, Jacqueline Benedetti, Christopher L. Corless, Ralph Wong, Eileen M. O’Reilly, Patrick J. Flynn, Kendrith M. Rowland, James N. Atkins, B. Mirtsching, Saul E. Rivkin, Alok A. Khorana, Bryan Goldman, Cecilia M. Fenoglio‐Preiser, James L. Abbruzzese, Charles D. Blanke

    Publicado 2010
    Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: